Indiana University Health Methodist Hospital is a hospital part of Indiana University Health, located in Indianapolis, state of Indiana, United States. It is the largest hospital in the state of Indiana and one of only three regional Level I Trauma Centers in the state.

There are 802 beds in Indiana University Health Methodist Research Institute.

During the past decade, Indiana University Health Methodist Research Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana University Health Methodist Research Institute" #1 sponsor was "APT Pharmaceuticals, Inc." with 2 trials, followed by "Medtronic" with 2 trials sponsored, "United Therapeutics" with 2 trials sponsored, "Agennix" with 1 trials sponsored and "Grifols Therapeutics LLC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana University Health Methodist Research Institute" #1 collaborator was "National Institute of General Medical Sciences (NIGMS)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Indiana University Health Methodist Research Institute" are "Lung Transplant" (2 trials), "Severe Sepsis" (2 trials), "Bradycardia" (1 trials), "Fecal Incontinence" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Indiana University Health Methodist Research Institute" in a lesser frequency.

Most popular intervention types in "Indiana University Health Methodist Research Institute" are "Drug" (6 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Cyclosporine Inhalation Solution (CIS)" (2 trials), "Oral treprostinil" (2 trials), "180 mg/kg Alpha1-PI" (1 trials) and "90 mg/kg Alpha1-PI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Indiana University Health Methodist Research Institute" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Indiana University Health Methodist Research Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Indiana University Health Methodist Research Institute, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Indiana University Health Methodist Research Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".